| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 141, Issue 9 3050-3054, Copyright © 1988 by American Association of Immunologists
ARTICLES |
JM Boswell, MA Yui, DW Burt and VE Kelley
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
Because TNF and IL-1 can initiate immunologic and inflammatory events alone or synergistically, a local increase in the levels of one or both of these cytokines in vivo may cause irreparable tissue damage. The purpose of this study was to evaluate local TNF and IL-1 beta gene expression in vivo in the kidneys of MRL-Ipr mice with autoimmune lupus nephritis. TNF mRNA was detected in the renal cortex of MRL-Ipr mice but was not present in the cortex of normal congenic MRL-++ or C3H/FeJ mice. MRL-Ipr mice with lupus nephritis expressed higher amounts of TNF mRNA compared with MRL-Ipr mice prior to disease. In addition, freshly isolated, unstimulated glomeruli from MRL-Ipr mice with nephritis were found to secrete detectable levels of TNF, whereas glomeruli from MRL- ++ mice did not. IL-1 beta mRNA, present in the renal cortex of C3H/FeJ, MRL-++, and young MRL-Ipr mice with normal kidneys, was also more abundantly expressed in MRL-Ipr mice with nephritis. Cultured macrophages from glomeruli of mice with nephritis were found to express TNF and IL-1 beta mRNA and product. These macrophages are prominent only in MRL-Ipr mice with renal disease and are the likely source of increased gene expression for both cytokines.
This article has been cited by other articles:
|
|
 |
|
  A. Y. Hoi, M. J. Hickey, P. Hall, J. Yamana, K. M. O'Sullivan, L. L. Santos, W. G. James, A. R. Kitching, and E. F. Morand Macrophage Migration Inhibitory Factor Deficiency Attenuates Macrophage Recruitment, Glomerulonephritis, and Lethality in MRL/lpr Mice J. Immunol., October 15, 2006; 177(8): 5687 - 5696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Navarra Immune therapy of lupus: what is on the horizon? Nephrol. Dial. Transplant., March 1, 2006; 21(3): 579 - 581. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yung, R. C.W. Tsang, Y. Sun, J. K.H. Leung, and T. M. Chan Effect of Human Anti-DNA Antibodies on Proximal Renal Tubular Epithelial Cell Cytokine Expression: Implications on Tubulointerstitial Inflammation in Lupus Nephritis J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3281 - 3294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bao, I. Osawe, M. Haas, and R. J. Quigg Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis J. Immunol., August 1, 2005; 175(3): 1947 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J S Smolen, G Steiner, and M Aringer Anti-cytokine therapy in systemic lupus erythematosus Lupus, March 1, 2005; 14(3): 189 - 191. [Abstract] [PDF]
|
|
|
|
|
|
M Aringer and J S Smolen Cytokine expression in lupus kidneys Lupus, January 1, 2005; 14(1): 13 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 J. R. Timoshanko, A. R. Kitching, Y. Iwakura, S. R. Holdsworth, and P. G. Tipping Leukocyte-Derived Interleukin-1{beta} Interacts with Renal Interleukin-1 Receptor I to Promote Renal Tumor Necrosis Factor and Glomerular Injury in Murine Crescentic Glomerulonephritis Am. J. Pathol., June 1, 2004; 164(6): 1967 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Aringer and J S Smolen Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention Lupus, May 1, 2004; 13(5): 344 - 347. [Abstract] [PDF]
|
|
|
|
|
|
L. Bao, M. Haas, D. M. Kraus, B. K. Hack, J. K. Rakstang, V. M. Holers, and R. J. Quigg Administration of a Soluble Recombinant Complement C3 Inhibitor Protects Against Renal Disease in MRL/lpr Mice J. Am. Soc. Nephrol., March 1, 2003; 14(3): 670 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Aringer, E Feierl, G Steiner, G H Stummvoll, E Hofler, C W Steiner, I Radda, J S Smolen, and W B Graninger Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death Lupus, February 1, 2002; 11(2): 102 - 108. [Abstract] [PDF]
|
|
|
|
|
|
R Segal, M Dayan, H Zinger, and E Mozes Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNF{alpha} monoclonal antibody and by pentoxiphylline Lupus, January 1, 2001; 10(1): 23 - 31. [Abstract] [PDF]
|
|
|
|
|
|
H. Yamagishi, T. Yokoo, T. Imasawa, T. Mitarai, T. Kawamura, and Y. Utsunomiya Genetically Modified Bone Marrow-Derived Vehicle Cells Site Specifically Deliver an Anti-Inflammatory Cytokine to Inflamed Interstitium of Obstructive Nephropathy J. Immunol., January 1, 2001; 166(1): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Toro, D. Finlay, X. Dou, S. C. Zheng, P. E. LeBoit, and M. K. Connolly Detection of Type 1 Cytokines in Discoid Lupus Erythematosus Arch Dermatol, December 1, 2000; 136(12): 1497 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schwarting, G. Tesch, K. Kinoshita, R. Maron, H. L. Weiner, and V. R. Kelley IL-12 Drives IFN-{gamma}-Dependent Autoimmune Kidney Disease in MRL-Faslpr Mice J. Immunol., December 15, 1999; 163(12): 6884 - 6891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zavala, A. Masson, K. Hadaya, S. Ezine, E. Schneider, O. Babin, and J.-F. Bach Granulocyte-Colony Stimulating Factor Treatment of Lupus Autoimmune Disease in MRL-lpr/lpr Mice J. Immunol., November 1, 1999; 163(9): 5125 - 5132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. McHale, O. A. Harari, D. Marshall, and D. O. Haskard TNF-{alpha} and IL-1 Sequentially Induce Endothelial ICAM-1 and VCAM-1 Expression in MRL/lpr Lupus-Prone Mice J. Immunol., October 1, 1999; 163(7): 3993 - 4000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamamoto and D. J. Loskutoff Extrahepatic Expression and Regulation of Protein C in the Mouse Am. J. Pathol., August 1, 1998; 153(2): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schwarting, T. Wada, K. Kinoshita, G. Tesch, and V. Rubin Kelley IFN-{gamma} Receptor Signaling Is Essential for the Initiation, Acceleration, and Destruction of Autoimmune Kidney Disease in MRL-Faslpr Mice J. Immunol., July 1, 1998; 161(1): 494 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schwarting, K. Moore, T. Wada, G. Tesch, H.-J. Yoon, and V. R. Kelley IFN-{gamma} Limits Macrophage Expansion in MRL-Faslpr Autoimmune Interstitial Nephritis: A Negative Regulatory Pathway J. Immunol., April 15, 1998; 160(8): 4074 - 4081. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
